Veradigm Inc. Files 8-K on Financials
| Field | Detail |
|---|---|
| Company | Veradigm Inc. |
| Form Type | 8-K |
| Filed Date | Sep 30, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K, results-of-operations
TL;DR
Veradigm dropped its 8-K on 9/30/25 covering financials. Check it out.
AI Summary
Veradigm Inc. filed an 8-K report on September 30, 2025, detailing results of operations and financial condition, along with financial statements and exhibits. The company, formerly known as Allscripts Healthcare Solutions, Inc., is incorporated in Delaware and headquartered in Chicago, Illinois.
Why It Matters
This filing provides crucial updates on Veradigm Inc.'s financial performance and condition, which is essential for investors and stakeholders to assess the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) and does not inherently indicate new risks or significant negative events.
Key Players & Entities
- Veradigm Inc. (company) — Registrant
- September 30, 2025 (date) — Date of earliest event reported
- Allscripts Healthcare Solutions, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of Incorporation
- Chicago, Illinois (location) — Business and Mail Address City/State
FAQ
What specific financial information is being reported in this 8-K filing?
The filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was the earliest event reported in this filing?
The earliest event reported was on September 30, 2025.
What is Veradigm Inc.'s state of incorporation?
Veradigm Inc. is incorporated in Delaware.
What were Veradigm Inc.'s previous names?
Veradigm Inc. was formerly known as Allscripts Healthcare Solutions, Inc., Allscripts-Misys Healthcare Solutions, Inc., and Allscripts Healthcare Solutions Inc.
Where is Veradigm Inc. headquartered?
Veradigm Inc. is headquartered at 222 Merchandise Mart Plaza, Suite 2024, Chicago, Illinois.
Filing Stats: 602 words · 2 min read · ~2 pages · Grade level 12.4 · Accepted 2025-09-30 16:10:28
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share MDRX N/A (OTC Expert Mark
Filing Documents
- mdrx-20250930.htm (8-K) — 48KB
- mdrx-ex99_1.htm (EX-99.1) — 107KB
- img154799912_0.jpg (GRAPHIC) — 161KB
- img154799912_1.jpg (GRAPHIC) — 161KB
- 0001193125-25-225033.txt ( ) — 709KB
- mdrx-20250930.xsd (EX-101.SCH) — 23KB
- mdrx-20250930_htm.xml (XML) — 4KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On September 30, 2025, Veradigm Inc., a Delaware corporation (the "Company"), announced that it has provided a preliminary estimated, unaudited range of GAAP revenue for the three and six months ended June 30, 2025 and preliminary estimated, unaudited cash and debt positions as of June 30, 2025, and December 31, 2024, along with certain other financial information (collectively, the "Financial Information"). The Financial Information is contained in the press release attached hereto as Exhibit 99.1, which also contains a reaffirmation of the Company's financial outlook for fiscal year 2025, originally provided on March 18, 2025, and reaffirmed on June 23, 2025, and is incorporated herein by reference. The Financial Information is preliminary, and final results may change. These preliminary results are based upon the Company's estimates and are subject to completion of the Company's financial closing procedures. In addition, these preliminary results have not been audited by the Company's independent registered public accounting firm. The information furnished pursuant to this Item 2.02 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. 99.1 Press release issued by Veradigm Inc. on September 30, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VERADIGM INC. Date: September 30, 2025 By: /s/ Leland Westerfield Leland Westerfield Interim Chief Financial Officer